IM8 Drives Prenetics Growth
Prenetics' IM8 Brand Posts Record Q2 Revenue, Raises Full-Year Guidance
Key Points
IM8 was co-founded by David Beckham, highlighting the brand's celebrity backing.
New investor materials will include monthly cohort economics and independent third-party card data to enhance transparency.
July was IM8's strongest month in company history, driving a higher annualized revenue run-rate.
Prenetics will host a live earnings webcast and offer a live earnings stream with direct Q&A during results discussion.
Prenetics Global posted a blowout second quarter, with total revenue jumping to $46.5 million — nearly four times the $12 million it reported a year earlier, according to Market Screener. The company's flagship health brand IM8, co-founded with celebrity David Beckham, drove the surge, posting $45.5 million in Q2 revenue, up 288% year-over-year, according to TipRanks.
On the back of that performance, Prenetics raised its full-year IM8 revenue guidance to $220–$230 million, topping Wall Street's prior estimate of $214 million, according to Benzinga. The company also issued early FY2027 guidance, targeting more than $400 million in IM8 revenue.
IM8 Posts Its Sixth Straight Record Quarter
IM8 has now delivered six consecutive record quarters since launching just 20 months ago. CEO Danny Yeung called the results the culmination of rapid brand-building, with July 2025 marking IM8's single strongest month in company history. That milestone pushed the brand's annualized revenue run-rate even higher heading into the back half of the year, according to TipRanks.
The momentum is expected to carry into Q3. Prenetics guided for Q3 sales of $63–$64 million, well above the analyst estimate of $59.3 million, according to Benzinga. The company said ongoing product launches will support continued revenue expansion through the rest of 2026.
Free Cash Flow Turns Positive for the First Time
One of the biggest milestones in the quarter was financial, not just operational. Prenetics said its consolidated adjusted free cash flow turned positive for the first time. Free cash flow is the money left over after a company pays its operating costs and investments — a key sign of financial health. The company expects it to stay positive going forward, according to TipRanks.
That shift marks a turning point for a company that has invested heavily in building IM8 from scratch. Reaching positive cash flow just 20 months after launch signals that the brand is now generating more money than it spends to operate and grow.
$400 Million FY2027 Target Signals Major Ambition
Prenetics went beyond its 2026 update, issuing early guidance for FY2027. The company is targeting more than $400 million in IM8 revenue next year — nearly double the top end of its 2026 guidance range of $230 million, according to Benzinga. That would make IM8 one of the largest brands in its market segment.
The company has not yet detailed exactly how it plans to hit that number. Additional details are expected in the shareholder letter and investor presentation tied to this earnings release.
Prenetics Overhauls How It Shares Results With Investors
Alongside its earnings, Prenetics announced a major shift in how it communicates with investors. The company will now publish a detailed shareholder letter, a full investor presentation, and monthly cohort economics — data showing how different groups of customers behave over time. It will also include independent third-party card data to back up its revenue claims.
The company will host a live earnings webcast with direct Q&A, giving investors a chance to ask questions in real time. The move signals a push toward greater openness after a period of rapid growth, and mirrors the reporting standards used by more mature public companies, according to TipRanks.
Sentiment
Mostly NegativePublishers
12
Articles
31
Reach
43
